- Home
- RYTM vs ALIT Comparison
RYTM vs ALIT Comparison
Compare RYTM & ALIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- ALIT
- Stock Information
- Founded
- RYTM 2008
- ALIT 2017
- Country
- RYTM United States
- ALIT United States
- Employees
- RYTM N/A
- ALIT N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- ALIT Business Services
- Sector
- RYTM Health Care
- ALIT Consumer Discretionary
- Exchange
- RYTM Nasdaq
- ALIT Nasdaq
- Market Cap
- RYTM 3.1B
- ALIT 3.7B
- IPO Year
- RYTM 2017
- ALIT N/A
- Fundamental
- Price
- RYTM $56.12
- ALIT $6.86
- Analyst Decision
- RYTM Strong Buy
- ALIT Strong Buy
- Analyst Count
- RYTM 10
- ALIT 9
- Target Price
- RYTM $65.80
- ALIT $10.83
- AVG Volume (30 Days)
- RYTM 552.7K
- ALIT 5.9M
- Earning Date
- RYTM 11-05-2024
- ALIT 02-19-2025
- Dividend Yield
- RYTM N/A
- ALIT 0.58%
- EPS Growth
- RYTM N/A
- ALIT N/A
- EPS
- RYTM N/A
- ALIT N/A
- Revenue
- RYTM $112,530,000.00
- ALIT $3,358,000,000.00
- Revenue This Year
- RYTM $63.64
- ALIT N/A
- Revenue Next Year
- RYTM $42.98
- ALIT $3.63
- P/E Ratio
- RYTM N/A
- ALIT N/A
- Revenue Growth
- RYTM 81.55
- ALIT 26.91
- 52 Week Low
- RYTM $35.17
- ALIT $6.15
- 52 Week High
- RYTM $68.58
- ALIT $10.38
- Technical
- Relative Strength Index (RSI)
- RYTM 46.95
- ALIT 32.09
- Support Level
- RYTM $53.39
- ALIT $7.44
- Resistance Level
- RYTM $57.27
- ALIT $7.13
- Average True Range (ATR)
- RYTM 2.32
- ALIT 0.19
- MACD
- RYTM -0.55
- ALIT -0.10
- Stochastic Oscillator
- RYTM 33.21
- ALIT 12.60
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Geographically the company generates its revenue from the United states, Germany, and other with the majority being generated from the United states.
About ALIT Alight Inc.
Alight Inc is a provider of integrated, cloud-based human capital solutions that empower clients and employees to manage health, wealth and HR needs. Geographically, the company generates a majority of its revenue from the United States.